Central Bank & Trust’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Central Bank & Trust’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-249	Closed	-$13K	–	275
2017 Q4	$13K	Hold	249	–	–	﹤0.01%	226
2017 Q3	$14K	Sell	249 -115	-32%	-$6.74K	﹤0.01%	224
2017 Q2	$22K	Sell	364 -1,713	-82%	-$97.5K	0.01%	216
2017 Q1	$113K	Buy	+2,077	New	+$102K	0.03%	153

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Central Bank & Trust's BIVV Position: Q1 2018 in Review

Central Bank & Trust sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 249 shares — an estimated $13K sold.

Central Bank & Trust first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $113K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Central Bank & Trust reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Central Bank & Trust sold 249 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $13K.
Central Bank & Trust first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Central Bank & Trust's Bioverativ Inc. Common Stock position peaked at $113K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Central Bank & Trust's 13F filing for Q1 2018, filed 27 Apr 2018.